Imatinib (Teva)

What it is used for

1) IMATINIB-TEVA (imatinib) is indicated for the treatment of patients with chronic myeloid leukaemia (CML). 2) IMATINIB-TEVA (imatinib) is indicated for the treatment of adult and paediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) integrated with chemotherapy. 3) IMATINIB-TEVA (imatinib) is indicated for the treatment of adult patients with relapsed or refractory Ph+ ALL as monotherapy. 4) IMATINIB-TEVA (imatinib) is indicated for the treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene rearrangements, where conventional therapies have failed. 5) IMATINIB-TEVA (imatinib) is indicated for the treatment of adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL). 6) IMATINIB-TEVA (imatinib) is indicated for the treatment of adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP).

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Protect from Moisture
Store in Original Container
Shelf lifetime is 24 Months.
Store below 25 degrees Celsius
Protect from Moisture
Store in Original Container
Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Protect from Moisture
Store in Original Container
Shelf lifetime is 24 Months.
Store below 25 degrees Celsius
Protect from Moisture
Store in Original Container
Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Pregnant or planning a pregnancy?

For the active ingredient imatinib

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

Visual appearance

Imatinib tablets 400 mg are dark yellow to brownish oblong film coated tablets debossed with IT and 4 divided by score line on one side.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.